Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection

Medical Science Monitor

Volumn 13, Issue 2, 2007, Pages

  Stasikowska, Olga ^a   Wa̧growska Danilewicz, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chemokines; Chemokines receptor; Glomerulonephritis; Renal allograft rejection

Indexed keywords

CD45 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

CYTOKINE PRODUCTION; DISEASE SEVERITY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; GLOMERULONEPHRITIS; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY PARENCHYMA; KIDNEY TUBULE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW;

ANIMALS; CHEMOKINES; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; RECEPTORS, CHEMOKINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846897484     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol, 2000; 11: 152-76
2. Schlondorff D, Nelson PJ, Luckow B, Banas B: Chemokines and renal disease. Kidney Int, 1997; 51: 610-62
3. Mackay CR: Chemokines: What chemokine is that? Curr Biol, 1997; 7: R384-86
4. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol, 1994; 55: 97-179
5. Murdoch C, Finn A: Chemokine receptors and their role in inflammation and infectious diseases. Blood, 2000; 95 3032-43
6. Murphy PM, Baggiolini M, Charo IF et al: International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev, 2000; 52: 145-76
7. Feng L, Xia Y, Kreisberg JI, Wilson CB: Interleukin-1-alpha stimulates KC synthesis in rat mesangial cells: Glucocorticoids inhibit KC induction by IL-1. Am J Physiol, 1994; 266: F713-22
8. Poon M, Megyesi J, Green RS et al: In vivo and in vitro inhibition of JE gene expression by glucocorticoid. J Biol Chem, 1991; 266: 22375-79
9. Gerritsma JS, van Kooten C, Gerritsen AF et al: Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int, 1998; 53: 609-16
10. Satriano JA, Hora K, Shan Z et al: Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by INF-gamma, tumor necrosis factor-alpha, IgG aggregates and cAMP in mouse mesangial cells. J Immunol, 1993; 150: 1971-78
11. Lloyd CM, Minto AW, Dorf ME et al: RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med, 1997; 185: 1371-80
12. Tesch GH, Schwarting A, Kinoshita K et al: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury in nephrotoxic serum nephritis. J Clin Invest, 1999; 103: 73-80
13. Schadde E, Kretzler M, Banas B et al: Chemokine receptor 1 to 5 expression in mouse anti-GMB-nephritis. J Am Soc Nephrol, 1997; 8: 485A
14. Neugarten J, Feith GW, Assmann KJ et al: Role of macrophages and colony-stimulating factor-1 in murine antiglomerular basement membrane glomerulonephritis. J Am Soc Nephrol, 1995; 5: 1903-9
15. Topham P, Hines D, Csizmadia V et al: Regulatory role of CCR1 pathway in glomerulonephritis (GN): CCR1 knockout mice show enhanced glomerular injury. J Am Soc Nephrol, 1998; 9: 487A
16. Rovin BH, Rumancik M, Tan L, Dickerson J: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest, 1994; 71: 536-42
17. Chen S, Bacon KB, Li L et al: In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephtitis in Wistar-Kyoto (WKY) rats by MIP-2. J Exp Med, 1998; 188: 193-98
18. Seikiguchi M, Natori Y, Iyonaga K, Takeya M: Expression of monocyte chemoattractant protein-1 in experimental crescentic glomerulonephritis in rats. J Lab Clin Med, 1997; 129: 239-44
19. Wada T, Yokoyama H, Furuichi K et al: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J, 1996; 10: 1418-25
20. Topham PS, Csizmadia V, Soler D et al: Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest, 1999; 104: 1549-57
21. Natori Y, Sekiguchi M, Ou ZL, Natori Y: Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin Exp Immunol, 1997; 109: 143-48
22. Wu X, Dolecki GJ, Sherry B et al: Chemokines are expressed in myeloid cell-dependent fashion and mediate distinct functional in immune complex glomerulonephritis in rat. J Immunol, 1997; 158: 3917-24
23. Tang WW, Yin S, Witter AJ, Qi M: Chemokine gene expression in antiglomerular basement membrane antibody glomerulonephritis. Am J Physiol, 1995; 269: F323-30
24. Schneider A, Harendza S, Zahner G et al: Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int, 1999; 55: 430-44
25. Fujinaka H, Yamamoto T, Feng L et al: Crucial role of CD-8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats. J Immunol, 1997; 158: 4978-83
26. Fujinaka H, Yamamoto T, Tekeya M et al: Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats. J Am Soc Nephrol, 1997; 8: 1174-78
27. Sakurai H, Hisada Y, Ueno M et al: Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim Biophys Acta, 1996; 1316: 132-38
28. Feng L, Xia Y, Yoshimura T, Wilson CB: Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest, 1995; 95: 1009-17
29. Zoja C, Liu XH, Donadelli R et al: Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol, 1997; 8: 720-29
30. Moore KJ, Wada T, Barbee SD, Kelley VR: Gene transfer of RANTES elicits autoimmune renal injury in MLR-Fas(1pr) mice. Kidney Int, 1998; 53: 1631-41
31. Anders HJ, Vielhauer V, Kretzler M et al: Chemokine and chemokine receptor expressing during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol, 2001; 12: 910-31
32. Anders HJ, Vielhauer V, Segerer S et al: CC-chemokine and receptor expression during immune-complex glomerulonephritis in mice. J Am Soc Nephrol, 1999; 10: 525A
33. Wada T, Furuichi K, Sakai N et al: Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesion of human diabetic nephropathy. Kidney Int, 2000; 58: 1492-99
34. Ou ZL, Hotta O, Natori Y et al: Enhanced expression of C chemokine lymphotactin in IgA nephropathy. Nephron, 2002; 91: 262-69
35. Yokoyama H, Wada T, Furuichi K et al: Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct activities and phases of human IgA nephropathy. J Leukocyte Biol, 1998; 63: 493-99
36. Prodjosudjadi W, Gerritsma JSJ, Van Es LA et al: Monocyte chemoattractant protein-1 in normal and diseased human kidneys. An immunohistochemical analysis. Clin Nephrol, 1995; 44: 148-55
37. Grandaliano G, Gesualdo L, Ranieri E et al: Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol, 1996; 7: 906-13
38. Prodjosudjadi W, Gerritsma JS, Klar MN et al: Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int, 1995; 48: 1477-86
39. Yamauchi F, Keshem A, Endoh M et al: Detection of monocyte chemoattractant protein-1 (MCP-1) and its receptors in mesangial proliferative glomerulonephritis. Nephrology, 1996; 2: 930-99
40. Segerer S, Mack M, Regele H et al: Expression of the C-C chemokine receptor 5 in human kidney disease. Kidney Int, 1999; 56: 52-64
41. Romagnani P, Beltrame C, Annunziato F et al: Role for interaction between IP-10/MIG and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol, 1999; 10: 2518-26
42. Wada T, Furuichi K, Segawa-Takaeda Ch et al: MIP-1 and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int, 1999; 56: 995-1003
43. Cocwell P, Howie AJ, Adu D, Savage COS: In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int, 1998; 54: 827-36
44. Cockwell P, Brooks CJ, Adu D, Savage COS: Interleukin-8: A pathogenic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int, 1999; 55: 852-63
45. Gesualdo L, Grandaliano G, Ranieri E et al: Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: A pathogenetic role for monocyte chemotactic peptide-1. Kidney Int, 1997; 51: 155-63
46. Wada T, Yokoyama H, Tomosugi N et al: Detection of urinary interleukin-8 in glomerular diseases. Kidney Int, 1994; 46: 455-60
47. Wada T, Yokoyama H, Su SB et al: Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int, 1996; 49: 761-67
48. Rovin BH, Doe N, Tan LC: Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis, 1996; 27: 640-46
49. Noris M, Bernasconi S, Casiraghi F et al: Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest, 1995; 73: 804-9
50. Shimizu H, Maruyama S, Yuzawa Y et al: Anti monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol, 2003; 14: 1496-505
51. Remuzzi G: A unifying hypothesis for renal scarring linking protein traf-ficking to the different mediators of injury. Nephrol Dial Transplant, 2000; 15(Suppl.6): 58-60
52. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int, 1995; 47: 1546-57
53. Zoja C, Benigni A, Remuzzi G: Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators. Exp Nephrol, 1999; 7: 420-28
54. Eddy AA: Proteinuria and interstitial injury. Nephrol Dial Transplant, 2004; 19: 277-81
55. Takase O, Hirahashi J, Takayanagi A et al: Gene transfer of truncated IκBα prevents tubulointerstitial injury. Kidney Int, 2003; 63: 501-13
56. Burton CJ, Combe C, Walls J, Harris KPG: Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. Nephrol Dial Transplant, 1999; 14: 2628-33
57. Morii T, Fujita H, Narita T et al: Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases. Ren Fail, 2003; 25(3): 439-44
58. Zafiriou S, Stanners SR, Polhill TS et al: Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic response. Kidney Int, 2004; 65(5): 1647-53
59. Hall BM, Bishop GA, Farnsworth A et al: Identification of the cellular subpopulations infiltrating rejecting cadaver renal allografts: Preponderance of the T4 subset of T cells. Transplantation, 1984; 37: 564-70
60. Hall BM: Cells mediating allograft rejection. Transplantation, 1991; 51: 1141-51
61. Nicholas G, Cockwell I, Cockwell P: The evolving role of chemokines and their receptors in acute allograft rejection. Nephrol Dial Transplant, 2002; 17: 1374-79
62. Erren M, Arlt M, Willeke P et al: Predictive value of CD45RO positive T-helper lymphocyte subsets for acute cellular rejection during the early phase after kidney transplantation. Transplantation Proc, 1999; 31: 319-21
63. Segerer S, Cui Y, Eitner F et al: Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis, 2001; 37: 518-31
64. Robertson H, Wheeler J, Morley AR et al: Beta-chemokine expression and distribution in paraffin-embedded transplant renal biopsy section: analysis by scanning laser confocal microscopy. Histochem Cell Biol, 1998; 110: 207-13
65. Grandaliano G, Gesualdo L, Ranieri E et al: Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation, 1997; 63: 414-20
66. Pattison J, Nelson PJ, Huie P et al: RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet, 1994; 343: 209-11
67. Budde K, Waiser J, Ceska M et al: Interleukine-8 expression in patients after renal transplantation. Am J Kidney Dis, 1997; 29: 871-80
68. Schmounder RL, Streiter RM, Walz A, Kunkel SL: Epithelial-derived neutrophil-activating factor-78 production in human renal tubule epithelial cells and in renal allograft rejection. Transplantation, 1995; 59: 118-24
69. von Leuttichau I, Nelson PJ et al: RANTES chemokine expression in diseased and normal human tissue. Cytokine, 1996; 8: 89-98
70. Robertson H, Morley AR, Talbot D et al: Renal allograft rejection: beta-chemokine involvement in development of tubulitis. Transplantation, 2000; 69: 684-87
71. Grau V, Gemsa D, Steiniger B, Garn H: Chemokine expression during acute rejection of rat kidney. Scand J Immunol, 2000; 51(5): 435-40
72. Sibbring JS, Sharma A, McDicken IW et al: Localization of C-X-C and C-C chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejection. Transpl Immunol, 1998; 6(4): 203-8
73. Ruster M, Sperschneider H, Funfstuck R et al: Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin Nephrol, 2004; 61(1): 30-39
74. Song E, Zou H, Yao Y et al: Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int, 2002; 61(2): 676-85
75. Nadeau KC, Azuma H, Tilney NL: Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA, 1995; 92(19): 8729-33
76. Corsi MM, Leone G, Fulgenzi A et al: RANTES and MCP-1 chemokine plasma level in chronic renal transplant dysfunction and chronic renal failure. Clin Biochem, 1999; 32: 455-60
77. Prodjosudjadi W, Daha MR, Gerritsma JS et al: Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Nephrol Dial Transplant, 1996; 11: 1096-103
78. Abdi R, Huong TTB, Sahagun-Ruiz A et al: Chemokine receptors polymorphism and risk factor of acute rejection in human renal transplant. J Am Soc Nephrol, 2002; 13: 754-58
79. Kruger B, Schroppel B, Ashkan R et al: A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol, 2002; 13: 2585-89